Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prescribing in Australia. Part 2.

R C Webb

    Australian Family Physician
    |March 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    This study analyzes Australian Pharmaceutical Benefits Scheme data to identify frequently prescribed drugs. It provides insights into medication trends within major pharmacological groups.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nuclear Recoil Calibration at Sub-keV Energies in LUX and Its Impact on Dark Matter Search Sensitivity.

    Physical review letters·2025
    Same author

    Constraints on Covariant Dark-Matter-Nucleon Effective Field Theory Interactions from the First Science Run of the LUX-ZEPLIN Experiment.

    Physical review letters·2024
    Same author

    First Dark Matter Search Results from the LUX-ZEPLIN (LZ) Experiment.

    Physical review letters·2023
    Same author

    Results of a Search for Sub-GeV Dark Matter Using 2013 LUX Data.

    Physical review letters·2019
    Same author

    Search for Sterile Neutrinos in MINOS and MINOS+ Using a Two-Detector Fit.

    Physical review letters·2019
    Same author

    First Searches for Axions and Axionlike Particles with the LUX Experiment.

    Physical review letters·2017
    Same journal

    Occupational violence and staff safety in general practice.

    Australian family physician·2018
    Same journal

    You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

    Australian family physician·2018
    Same journal

    Understanding the decision to commence a dose administration aid.

    Australian family physician·2018
    Same journal

    Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

    Australian family physician·2018
    Same journal

    A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

    Australian family physician·2018
    Same journal

    The Australian Mid-West Coastal Marine Wound Infections Study.

    Australian family physician·2018
    See all related articles

    Area of Science:

    • Health economics
    • Pharmacology
    • Public health policy

    Background:

    • The Australian Pharmaceutical Benefits Scheme (PBS) provides access to subsidized prescription medications.
    • Understanding drug utilization patterns is crucial for healthcare resource allocation and policy development.

    Purpose of the Study:

    • To provide a historical overview of the Australian Pharmaceutical Benefits Scheme (PBS).
    • To analyze recent statistical data on drug prescription frequency within the PBS.
    • To identify commonly prescribed medications individually and by major pharmacological groups.

    Main Methods:

    • Historical review of the PBS.
    • Statistical analysis of available prescription data from recent years.
    • Categorization of drugs into major pharmacological groups.

    Related Experiment Videos

    Main Results:

    • Identification of the most frequently prescribed drugs under the PBS.
    • Analysis of prescription trends across different pharmacological categories.
    • Part 1 of the analysis, focusing on antibiotics and analgesics, was previously published.

    Conclusions:

    • The analysis offers insights into prescribing habits and medication usage within the Australian healthcare system.
    • Understanding these trends is vital for effective pharmaceutical policy and management.
    • Further analysis across other drug classes is implied by the mention of Part 1.